Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Flow Cytometry Analysis of Blood Large Extracellular Vesicles in Patients with Multiple Sclerosis Experiencing Relapse of the Disease

J. Soukup, M. Kostelanská, S. Kereïche, A. Hujacová, M. Pavelcová, J. Petrák, E. Kubala Havrdová, K. Holada

. 2022 ; 11 (10) : . [pub] 20220517

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22017141

Grantová podpora
15-32961A Ministry of Health of the Czech Republic
360216 Charles University

The number of people living with multiple sclerosis (MS) in developed countries is increasing. The management of patients is hindered by the absence of reliable laboratory tests accurately reflecting the disease activity. Extracellular vesicles (EVs) of different cell origin were reportedly elevated in MS patients. We assessed the diagnostic potential, with flow cytometry analysis, of fresh large EVs (lEVs), which scattered more light than the 590 nm silica beads and were isolated from the blood plasma of relapsing remitting MS patients. Venous blood was collected from 15 patients and 16 healthy controls (HC). The lEVs were isolated from fresh platelet-free plasma by centrifugation, labelled with antibodies and the presence of platelet (CD41+, CD36+), endothelial (CD105+), erythrocyte (CD235a+), leukocyte (CD45+, CD19+, CD3+) and phosphatidylserine (Annexin V+) positive lEVs was analyzed using standard flow cytometry. Cryo-electron microscopy was used to verify the presence of EVs in the analyzed plasma fractions. MS patients experiencing acute relapse had slightly reduced relative levels (% of positive lEVs) of CD105+, CD45+, CD3+, CD45+CD3+ or CD19+ labelled lEVs in comparison to healthy controls. An analysis of other markers or a comparison of absolute lEV counts (count of lEVs/μL) did not yield any significant differences. Our data do not support the hypothesis that the exacerbation of the disease in RRMS patients leads to an increased numbers of circulating plasma lEVs which can be monitored by standard flow cytometry.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22017141
003      
CZ-PrNML
005      
20220720100124.0
007      
ta
008      
220718s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/jcm11102832 $2 doi
035    __
$a (PubMed)35628959
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Soukup, Jakub $u Institute of Immunology and Microbiology, First Faculty of Medicine, Charles University, 128 00 Prague, Czech Republic $u Department of Genetics and Microbiology, Faculty of Science, Charles University, 128 44 Prague, Czech Republic $1 https://orcid.org/0000000204599394
245    10
$a Flow Cytometry Analysis of Blood Large Extracellular Vesicles in Patients with Multiple Sclerosis Experiencing Relapse of the Disease / $c J. Soukup, M. Kostelanská, S. Kereïche, A. Hujacová, M. Pavelcová, J. Petrák, E. Kubala Havrdová, K. Holada
520    9_
$a The number of people living with multiple sclerosis (MS) in developed countries is increasing. The management of patients is hindered by the absence of reliable laboratory tests accurately reflecting the disease activity. Extracellular vesicles (EVs) of different cell origin were reportedly elevated in MS patients. We assessed the diagnostic potential, with flow cytometry analysis, of fresh large EVs (lEVs), which scattered more light than the 590 nm silica beads and were isolated from the blood plasma of relapsing remitting MS patients. Venous blood was collected from 15 patients and 16 healthy controls (HC). The lEVs were isolated from fresh platelet-free plasma by centrifugation, labelled with antibodies and the presence of platelet (CD41+, CD36+), endothelial (CD105+), erythrocyte (CD235a+), leukocyte (CD45+, CD19+, CD3+) and phosphatidylserine (Annexin V+) positive lEVs was analyzed using standard flow cytometry. Cryo-electron microscopy was used to verify the presence of EVs in the analyzed plasma fractions. MS patients experiencing acute relapse had slightly reduced relative levels (% of positive lEVs) of CD105+, CD45+, CD3+, CD45+CD3+ or CD19+ labelled lEVs in comparison to healthy controls. An analysis of other markers or a comparison of absolute lEV counts (count of lEVs/μL) did not yield any significant differences. Our data do not support the hypothesis that the exacerbation of the disease in RRMS patients leads to an increased numbers of circulating plasma lEVs which can be monitored by standard flow cytometry.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Kostelanská, Marie $u Institute of Immunology and Microbiology, First Faculty of Medicine, Charles University, 128 00 Prague, Czech Republic
700    1_
$a Kereïche, Sami $u Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University, 128 00 Prague, Czech Republic
700    1_
$a Hujacová, Andrea $u Institute of Immunology and Microbiology, First Faculty of Medicine, Charles University, 128 00 Prague, Czech Republic
700    1_
$a Pavelcová, Miluše $u Department of Neurology and Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, 128 21 Prague, Czech Republic $1 https://orcid.org/0000000152298759
700    1_
$a Petrák, Jiří $u BIOCEV, First Faculty of Medicine, Charles University, 252 50 Vestec, Czech Republic $1 https://orcid.org/0000000286954803
700    1_
$a Kubala Havrdová, Eva $u Department of Neurology and Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, 128 21 Prague, Czech Republic
700    1_
$a Holada, Karel $u Institute of Immunology and Microbiology, First Faculty of Medicine, Charles University, 128 00 Prague, Czech Republic $1 https://orcid.org/0000000237682629 $7 xx0061473
773    0_
$w MED00195462 $t Journal of clinical medicine $x 2077-0383 $g Roč. 11, č. 10 (2022)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35628959 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20220718 $b ABA008
991    __
$a 20220720100120 $b ABA008
999    __
$a ind $b bmc $g 1816458 $s 1168383
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 11 $c 10 $e 20220517 $i 2077-0383 $m Journal of clinical medicine $n J Clin Med $x MED00195462
GRA    __
$a 15-32961A $p Ministry of Health of the Czech Republic
GRA    __
$a 360216 $p Charles University
LZP    __
$a Pubmed-20220718

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace